LOWE CHRISTOPHER P.
Insider CIK 1376260 · HNSN Interim CFO, Director · ANTH CFO and Chief Business Officer · CRTX Interim CEO, COO & CFO · VINC Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| VINC Vincerx Pharma, Inc. | P Buy | 2022-08-25 | 2022-08-26 | 11,600 | $1.65 | $19.1K | 40,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2022-08-24 | 2022-08-26 | 18,400 | $1.65 | $30.4K | 28,400 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2022-05-26 | 2022-05-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award | 2022-03-03 | 2022-03-04 | 175,000 | — | $0 | 265,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2022-01-03 | 2022-01-05 | 125,000 | — | $0 | 125,000 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise deriv | 2021-11-16 | 2021-11-16 | 30,000 | — | $0 | 103,294 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise | 2021-11-16 | 2021-11-16 | 30,000 | $2.23 | $66.9K | 90,000 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise deriv | 2021-10-05 | 2021-10-07 | 4,963 | — | $0 | 95,037 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise | 2021-10-05 | 2021-10-07 | 4,963 | $54.85 | $272.2K | 64,963 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-10-05 | 2021-10-07 | 4,963 | $98.50 | $488.9K | 60,000 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise deriv | 2021-08-17 | 2021-08-18 | 30,000 | — | $0 | 133,294 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise | 2021-08-17 | 2021-08-18 | 30,000 | $2.23 | $66.9K | 60,000 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise deriv | 2021-08-16 | 2021-08-18 | 22,000 | — | $0 | 163,294 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-08-16 | 2021-08-18 | 2,330 | $96.32 | $224.4K | 33,177 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise | 2021-08-16 | 2021-08-18 | 22,000 | $2.23 | $49.1K | 52,000 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-08-16 | 2021-08-18 | 9,158 | $94.23 | $863.0K | 42,842 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-08-16 | 2021-08-18 | 7,335 | $95.02 | $697.0K | 35,507 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-08-16 | 2021-08-18 | 2,077 | $98.90 | $205.4K | 30,000 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-08-16 | 2021-08-18 | 1,100 | $97.28 | $107.0K | 32,077 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise deriv | 2021-06-30 | 2021-06-30 | 30,000 | — | $0 | 185,294 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise | 2021-06-30 | 2021-06-30 | 30,000 | $2.23 | $66.9K | 30,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2021-06-30 | 2021-06-30 | 3,600 | $12.66 | $45.6K | 10,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | P Buy | 2021-06-29 | 2021-06-30 | 6,400 | $12.59 | $80.6K | 6,400 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise deriv | 2021-06-28 | 2021-06-30 | 20,000 | — | $0 | 215,594 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-06-28 | 2021-06-30 | 1,044 | $56.16 | $58.6K | 0 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-06-28 | 2021-06-30 | 4,153 | $55.11 | $228.9K | 1,044 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-06-28 | 2021-06-30 | 7,079 | $54.13 | $383.2K | 5,197 | SEC↗ |
| CRTX Cortexyme, Inc. | S Sale | 2021-06-28 | 2021-06-30 | 7,724 | $53.39 | $412.4K | 12,276 | SEC↗ |
| CRTX Cortexyme, Inc. | M Exercise | 2021-06-28 | 2021-06-30 | 20,000 | $2.23 | $44.6K | 20,000 | SEC↗ |
| VINC Vincerx Pharma, Inc. | A Award deriv | 2021-05-13 | 2021-05-14 | 20,000 | — | $0 | 20,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2021-02-09 | 2021-02-11 | 40,000 | — | $0 | 40,000 | SEC↗ |
| VINC Vincera Pharma, Inc. | A Award deriv | 2020-12-23 | 2020-12-28 | 6,667 | — | $0 | 6,667 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2020-12-11 | 2020-12-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2020-12-11 | 2020-12-15 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2020-05-14 | 2020-05-18 | 30,000 | — | $0 | 30,000 | SEC↗ |
| CRTX Cortexyme, Inc. | A Award deriv | 2020-02-06 | 2020-02-10 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HNSN HANSEN MEDICAL INC | D To issuer deriv | 2016-07-27 | 2016-07-29 | 100,000 | — | $0 | 0 | SEC↗ |
| HNSN HANSEN MEDICAL INC | D To issuer | 2016-07-27 | 2016-07-29 | 104,250 | $4.00 | $417.0K | 0 | SEC↗ |
| HNSN HANSEN MEDICAL INC | M Exercise | 2016-07-27 | 2016-07-29 | 100,000 | — | $0 | 104,250 | SEC↗ |
| HNSN HANSEN MEDICAL INC | A Award deriv | 2016-02-02 | 2016-02-04 | 100,000 | — | $0 | 100,000 | SEC↗ |
| HNSN HANSEN MEDICAL INC | A Award deriv | 2015-06-12 | 2015-06-15 | 75,000 | — | $0 | 75,000 | SEC↗ |
| HNSN HANSEN MEDICAL INC | A Award deriv | 2014-06-11 | 2014-06-12 | 75,000 | — | $0 | 75,000 | SEC↗ |
| HNSN HANSEN MEDICAL INC | P Buy | 2014-05-20 | 2014-05-20 | 20,000 | $1.44 | $28.8K | 42,500 | SEC↗ |
| HNSN HANSEN MEDICAL INC | A Award deriv | 2014-02-25 | 2014-02-27 | 120,000 | — | $0 | 120,000 | SEC↗ |
| HNSN HANSEN MEDICAL INC | A Award deriv | 2013-05-30 | 2013-06-03 | 30,000 | — | $0 | 30,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2013-05-17 | 2013-05-21 | 1,300,000 | — | $0 | 1,300,000 | SEC↗ |
| HNSN HANSEN MEDICAL INC | P Buy | 2013-05-13 | 2013-05-15 | 12,500 | $1.52 | $19.0K | 22,500 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2013-03-25 | 2013-03-27 | 67,579 | — | $0 | 108,915 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | F Tax w/h | 2013-01-03 | 2013-01-07 | 8,660 | $0.69 | $6.0K | 41,336 | SEC↗ |
| HNSN HANSEN MEDICAL INC | A Award deriv | 2012-05-25 | 2012-05-30 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award deriv | 2012-03-30 | 2012-04-03 | 80,000 | — | $0 | 80,000 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | A Award | 2012-02-06 | 2012-02-06 | 18,845 | — | $0 | 49,996 | SEC↗ |
| ANTH Anthera Pharmaceuticals In | S Sale | 2012-02-01 | 2012-02-03 | 15,000 | $7.66 | $114.9K | 31,151 | SEC↗ |